CARISMA Therapeutics

CARM

CARM CARISMA Therapeutics NASDAQ
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Financials
    News
    Filings
    Profile
    CARM Chart
    See on advanced chart >

    About

    CARISMA Therapeutics Inc. is a clinical-stage biopharmaceutical company with a proprietary protein engineering platform, called AMP-Rx, that it applys to the discovery and development of protein therapeutics to treat diseases of the eye. Its therapeutic...
    • Highlight
      A late-stage clinical company advancing targeted fusion protein therapeutics ("TFPTs") for the treatment of patients with cancer
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      02/06/2014
    • Established Date
      02/25/2008
    • Full-time Employees
      17
    • Address
      245 First Street Suite 1800 Cambridge MA 02142
    • Tel
      1-617-4448550
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock
    cache time: 2024-03-01 04:26:40